C57BL/6-Nrp1em1Cruh/H

Status

Available to order

EMMA IDEM:11988
International strain nameC57BL/6-Nrp1em1Cruh/H
Alternative nameNrp1 D320K
Strain typeEndonuclease-mediated
Allele/Transgene symbolNrp1em1Cruh
Gene/Transgene symbolNrp1

Information from provider

ProviderChristiana Ruhrberg
Provider affiliationUCL Institute of Ophthalmology, University College London
Genetic informationCRISPR/Cas9 technology introduced a lysine to aspartate substitution at amino acid 320 (D320K) which is predicted to abrogate VEGF164 binding to NRP1.
Phenotypic informationHomozygous:
Nrp1-D320K/D320K mice have significantly reduced VEGF164-induced permeability.

Heterozygous:
--
References
  • VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation.;Fantin Alessandro, Lampropoulou Anastasia, Senatore Valentina, Brash James T, Prahst Claudia, Lange Clemens A, Liyanage Sidath E, Raimondi Claudio, Bainbridge James W, Augustin Hellmut G, Ruhrberg Christiana, ;2017;The Journal of experimental medicine;214;1049-1064; 28289053
Homozygous fertilenot known
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

IMPC phenotypes (gene matching)
  • preweaning lethality, complete penetrance / IMPC
  • decreased prepulse inhibition / IMPC
  • abnormal auditory brainstem response / IMPC
MGI phenotypes (gene matching)
  • abnormal vascular development / MGI
  • abnormal pulmonary artery morphology / MGI
  • abnormal corpus callosum morphology / MGI
  • abnormal hippocampus morphology / MGI
  • abnormal facial motor nucleus morphology / MGI
  • abnormal dorsal root ganglion morphology / MGI
  • abnormal cranial nerve morphology / MGI
  • abnormal trigeminal nerve morphology / MGI
  • abnormal facial nerve morphology / MGI
  • abnormal vestibulocochlear nerve morphology / MGI
  • abnormal spinal nerve morphology / MGI
  • decreased body size / MGI
  • disorganized yolk sac vascular plexus / MGI
  • postnatal growth retardation / MGI
  • postnatal lethality / MGI
  • premature death / MGI
  • abnormal dendritic cell physiology / MGI
  • abnormal T cell physiology / MGI
  • persistent truncus arteriosis / MGI
  • abnormal pharyngeal arch artery morphology / MGI
  • abnormal retinal vasculature morphology / MGI
  • abnormal axon guidance / MGI
  • dilated heart atrium / MGI
  • decreased tumor growth/size / MGI
  • nervous system phenotype / MGI
  • vascular smooth muscle hypoplasia / MGI
  • transposition of great arteries / MGI
  • abnormal coronary artery morphology / MGI
  • right aortic arch / MGI
  • double aortic arch / MGI
  • abnormal dorsal aorta morphology / MGI
  • abnormal brain vasculature morphology / MGI
  • cardiovascular system phenotype / MGI
  • vision/eye phenotype / MGI
  • decreased angiogenesis / MGI
  • abnormal neuronal migration / MGI
  • abnormal fourth pharyngeal arch artery morphology / MGI
  • abnormal sixth pharyngeal arch artery morphology / MGI
  • abnormal third pharyngeal arch artery morphology / MGI
  • abnormal induced retinal neovascularization / MGI
  • abnormal retinal blood vessel morphology / MGI
  • abnormal retinal blood vessel pattern / MGI
  • abnormal first pharyngeal arch artery morphology / MGI
  • abnormal second pharyngeal arch artery morphology / MGI
  • abnormal aortic arch and aortic arch branch attachment / MGI
  • abnormal coronary vessel morphology / MGI
  • postnatal lethality, incomplete penetrance / MGI
  • embryonic lethality, complete penetrance / MGI
  • embryonic lethality during organogenesis, complete penetrance / MGI

Literature references

  • VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation.;Fantin Alessandro, Lampropoulou Anastasia, Senatore Valentina, Brash James T, Prahst Claudia, Lange Clemens A, Liyanage Sidath E, Raimondi Claudio, Bainbridge James W, Augustin Hellmut G, Ruhrberg Christiana, ;2017;The Journal of experimental medicine;214;1049-1064; 28289053

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*
  • Tissue - Types of tissue, service fee and delivery time available upon request

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).